{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "29628509",
  "DateCompleted": {
    "Year": "2019",
    "Month": "02",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2018",
        "Month": "04",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "18",
      "10.1038/s12276-018-0063-8"
    ],
    "Journal": {
      "ISSN": "2092-6413",
      "JournalIssue": {
        "Volume": "50",
        "Issue": "4",
        "PubDate": {
          "Year": "2018",
          "Month": "Apr",
          "Day": "09"
        }
      },
      "Title": "Experimental & molecular medicine",
      "ISOAbbreviation": "Exp Mol Med"
    },
    "ArticleTitle": "Inhibition in the amygdala anxiety circuitry.",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "16",
      "MedlinePgn": "1-16"
    },
    "Abstract": {
      "AbstractText": [
        "Inhibitory neurotransmission plays a key role in anxiety disorders, as evidenced by the anxiolytic effect of the benzodiazepine class of \u03b3-aminobutyric acid (GABA) receptor agonists and the recent discovery of anxiety-associated variants in the molecular components of inhibitory synapses. Accordingly, substantial interest has focused on understanding how inhibitory neurons and synapses contribute to the circuitry underlying adaptive and pathological anxiety behaviors. A key element of the anxiety circuitry is the amygdala, which integrates information from cortical and thalamic sensory inputs to generate fear and anxiety-related behavioral outputs. Information processing within the amygdala is heavily dependent on inhibitory control, although the specific mechanisms by which amygdala GABAergic neurons and synapses regulate anxiety-related behaviors are only beginning to be uncovered. Here, we summarize the current state of knowledge and highlight open questions regarding the role of inhibition in the amygdala anxiety circuitry. We discuss the inhibitory neuron subtypes that contribute to the processing of anxiety information in the basolateral and central amygdala, as well as the molecular determinants, such as GABA receptors and synapse organizer proteins, that shape inhibitory synaptic transmission within the anxiety circuitry. Finally, we conclude with an overview of current and future approaches for converting this knowledge into successful treatment strategies for anxiety disorders."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075, G\u00f6ttingen, Germany."
          }
        ],
        "LastName": "Babaev",
        "ForeName": "Olga",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075, G\u00f6ttingen, Germany."
          }
        ],
        "LastName": "Piletti Chatain",
        "ForeName": "Carolina",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075, G\u00f6ttingen, Germany. krueger@em.mpg.de."
          }
        ],
        "LastName": "Krueger-Burg",
        "ForeName": "Dilja",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Exp Mol Med",
    "NlmUniqueID": "9607880",
    "ISSNLinking": "1226-3613"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, GABA"
    },
    {
      "RegistryNumber": "56-12-2",
      "NameOfSubstance": "gamma-Aminobutyric Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Amygdala"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "metabolism",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biomarkers"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Models, Animal"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "GABAergic Neurons"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Neurons"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Receptors, GABA"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Signal Transduction"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Synapses"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Synaptic Transmission"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "gamma-Aminobutyric Acid"
    }
  ],
  "CoiStatement": "The authors declare that they have no conflict of interest."
}